IL165398A0 - Method for identifying immunoreactive peptides - Google Patents
Method for identifying immunoreactive peptidesInfo
- Publication number
- IL165398A0 IL165398A0 IL16539803A IL16539803A IL165398A0 IL 165398 A0 IL165398 A0 IL 165398A0 IL 16539803 A IL16539803 A IL 16539803A IL 16539803 A IL16539803 A IL 16539803A IL 165398 A0 IL165398 A0 IL 165398A0
- Authority
- IL
- Israel
- Prior art keywords
- peptides
- immunoreactive peptides
- identifying
- tumorous
- identifying immunoreactive
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C40—COMBINATORIAL TECHNOLOGY
- C40B—COMBINATORIAL CHEMISTRY; LIBRARIES, e.g. CHEMICAL LIBRARIES
- C40B30/00—Methods of screening libraries
- C40B30/04—Methods of screening libraries by measuring the ability to specifically bind a target molecule, e.g. antibody-antigen binding, receptor-ligand binding
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
- A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- A61K38/1703—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates
- A61K38/1709—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K39/0005—Vertebrate antigens
- A61K39/0011—Cancer antigens
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- C07K14/46—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates
- C07K14/47—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals
- C07K14/4701—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals not used
- C07K14/4748—Tumour specific antigens; Tumour rejection antigen precursors [TRAP], e.g. MAGE
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Medicinal Chemistry (AREA)
- Immunology (AREA)
- Organic Chemistry (AREA)
- Animal Behavior & Ethology (AREA)
- Veterinary Medicine (AREA)
- Pharmacology & Pharmacy (AREA)
- Public Health (AREA)
- Epidemiology (AREA)
- Molecular Biology (AREA)
- Mycology (AREA)
- Zoology (AREA)
- Gastroenterology & Hepatology (AREA)
- Microbiology (AREA)
- Oncology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- General Chemical & Material Sciences (AREA)
- Biochemistry (AREA)
- Marine Sciences & Fisheries (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Biophysics (AREA)
- Genetics & Genomics (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Engineering & Computer Science (AREA)
- Toxicology (AREA)
- Peptides Or Proteins (AREA)
- Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
- Investigating Or Analysing Biological Materials (AREA)
- Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Micro-Organisms Or Cultivation Processes Thereof (AREA)
- Other Investigation Or Analysis Of Materials By Electrical Means (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| DE10225139A DE10225139A1 (de) | 2002-05-29 | 2002-05-29 | Verfahren zur Identifizierung von immunreaktiven Peptiden |
| PCT/EP2003/005038 WO2003100432A2 (fr) | 2002-05-29 | 2003-05-14 | Procede pour identifier des peptides immunoreactifs |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| IL165398A0 true IL165398A0 (en) | 2006-01-15 |
Family
ID=29557590
Family Applications (2)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| IL16539803A IL165398A0 (en) | 2002-05-29 | 2003-05-14 | Method for identifying immunoreactive peptides |
| IL165398A IL165398A (en) | 2002-05-29 | 2004-11-25 | Method for identifying immunoreactive peptides |
Family Applications After (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| IL165398A IL165398A (en) | 2002-05-29 | 2004-11-25 | Method for identifying immunoreactive peptides |
Country Status (13)
| Country | Link |
|---|---|
| EP (1) | EP1508047B1 (fr) |
| JP (1) | JP2005535299A (fr) |
| AT (1) | ATE403874T1 (fr) |
| AU (1) | AU2003236645B2 (fr) |
| CA (1) | CA2486738C (fr) |
| CY (1) | CY1108358T1 (fr) |
| DE (2) | DE10225139A1 (fr) |
| DK (1) | DK1508047T3 (fr) |
| ES (1) | ES2311710T3 (fr) |
| IL (2) | IL165398A0 (fr) |
| PT (1) | PT1508047E (fr) |
| SI (1) | SI1508047T1 (fr) |
| WO (1) | WO2003100432A2 (fr) |
Families Citing this family (28)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JP2008503498A (ja) * | 2004-06-17 | 2008-02-07 | マンカインド コーポレイション | 癌の診断及び免疫療法における腫瘍関連抗原プロファイル |
| EP1994181A4 (fr) * | 2006-02-27 | 2010-05-19 | Univ Arizona | Identification et utilisation de novopeptides pour le traitement du cancer |
| US9732131B2 (en) | 2006-02-27 | 2017-08-15 | Calviri, Inc. | Identification and use of novopeptides for the treatment of cancer |
| US20090004213A1 (en) * | 2007-03-26 | 2009-01-01 | Immatics Biotechnologies Gmbh | Combination therapy using active immunotherapy |
| GB201004575D0 (en) | 2010-03-19 | 2010-05-05 | Immatics Biotechnologies Gmbh | Composition of tumor associated peptides and related anti cancer vaccine for the treatment of gastric cancer and other cancers |
| GB201019331D0 (en) * | 2010-03-19 | 2010-12-29 | Immatics Biotechnologies Gmbh | Methods for the diagnosis and treatment of cancer based on AVL9 |
| GB201004551D0 (en) | 2010-03-19 | 2010-05-05 | Immatics Biotechnologies Gmbh | NOvel immunotherapy against several tumors including gastrointestinal and gastric cancer |
| GB201006360D0 (en) | 2010-04-16 | 2010-06-02 | Immatics Biotechnologies Gmbh | Method for differentially quantifying naturally processed HLA-restricted peptides for cancer, autoimmune and infectious diseases immunotherapy development |
| GB201423361D0 (en) | 2014-12-30 | 2015-02-11 | Immatics Biotechnologies Gmbh | Method for the absolute Quantification of naturally processed HLA-Restricted cancer peptides |
| GB201604458D0 (en) | 2016-03-16 | 2016-04-27 | Immatics Biotechnologies Gmbh | Peptides and combination of peptides for use in immunotherapy against cancers |
| WO2017194170A1 (fr) | 2016-05-13 | 2017-11-16 | Biontech Rna Pharmaceuticals Gmbh | Procédés pour prédire l'utilité de protéines ou de fragments de protéines pour l'immunothérapie |
| KR102379955B1 (ko) | 2016-12-08 | 2022-03-29 | 이매틱스 바이오테크놀로지스 게엠베하 | 짝짓기가 향상된 t 세포 수용체 |
| DE102016123893A1 (de) | 2016-12-08 | 2018-06-14 | Immatics Biotechnologies Gmbh | T-Zellrezeptoren mit verbesserter Bindung |
| WO2018223092A1 (fr) | 2017-06-02 | 2018-12-06 | Arizona Board Of Regents On Behalf Of Arizona State University | Procédé de création de vaccins anticancéreux personnalisés |
| WO2019055618A1 (fr) | 2017-09-15 | 2019-03-21 | Arizona Board Of Regents On Behalf Of Arizona State University | Procédés de classification des réponses à une immunothérapie anticancéreuse |
| DE102018122546B3 (de) | 2018-09-14 | 2019-12-05 | Immatics Biotechnologies Gmbh | Verfahren zum Hochdurchsatz-Peptid-MHC-Affinitätsscreening für TCR-Liganden |
| DE102019114735A1 (de) * | 2019-06-02 | 2020-12-03 | PMCR GmbH | HLA-Tumorantigenpeptiden der Klasse I und II zur Behandlung von Mamma-/Brustkarzinomen |
| DE102019121007A1 (de) | 2019-08-02 | 2021-02-04 | Immatics Biotechnologies Gmbh | Antigenbindende Proteine, die spezifisch an MAGE-A binden |
| US20210032370A1 (en) | 2019-08-02 | 2021-02-04 | Immatics Biotechnologies Gmbh | Recruiting agent further binding an mhc molecule |
| WO2021067550A1 (fr) | 2019-10-02 | 2021-04-08 | Arizona Board Of Regents On Behalf Of Arizona State University | Procédés et compositions pour identifier des néo-antigènes destinés à être utilisés dans le traitement et la prévention du cancer |
| BR112023022765A2 (pt) | 2021-05-05 | 2024-01-02 | Immatics Biotechnologies Gmbh | Proteínas de ligação ao antígeno que ligam especificamente o prame |
| MX2024001179A (es) | 2021-07-27 | 2024-02-27 | Immatics Biotechnologies Gmbh | Proteinas de union a antigenos que se unen especificamente a ct45. |
| WO2025021968A1 (fr) | 2023-07-27 | 2025-01-30 | Immatics Biotechnologies Gmbh | Protéines de liaison à l'antigène dirigées contre mageb2 |
| WO2025021979A1 (fr) | 2023-07-27 | 2025-01-30 | Immatics Biotechnologies Gmbh | Nouveaux récepteurs de lymphocytes t ciblant un antigène associé au mélanome (mage) b2 et thérapie immunitaire l'utilisant |
| LU103243B1 (en) | 2024-02-09 | 2025-08-11 | PMCR GmbH | Click chemistry hla tumor antigen polypeptides and pharmaceutical composition comprising the same |
| WO2025168848A1 (fr) | 2024-02-09 | 2025-08-14 | IMMUNEO Therapeutics GmbH | Polypeptides d'antigène de tumeur hla avec administration de peptides de coiffage auxiliaires et composition pharmaceutique les comprenant |
| WO2025233432A1 (fr) | 2024-05-07 | 2025-11-13 | Immatics Biotechnologies Gmbh | Utilisation et dosage d'une protéine de liaison à l'antigène comprenant un tcr spécifique d'un peptide restreint par hla-a*02 |
| WO2025233431A1 (fr) | 2024-05-07 | 2025-11-13 | Immatics Biotechnologies Gmbh | Protéines hétéromères comprenant trois hétéromérisations améliorant la substitution, production, combinaisons et applications associées |
Family Cites Families (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US6156317A (en) * | 1996-11-12 | 2000-12-05 | City Of Hope | Immuno-reactive peptide CTL epitopes of human cytomegalovirus |
| DE10225144A1 (de) * | 2002-05-29 | 2003-12-18 | Immatics Biotechnologies Gmbh | An MHC-Moleküle bindende Tumor-assoziierte Peptide |
-
2002
- 2002-05-29 DE DE10225139A patent/DE10225139A1/de not_active Ceased
-
2003
- 2003-05-14 AT AT03735383T patent/ATE403874T1/de active
- 2003-05-14 SI SI200331284T patent/SI1508047T1/sl unknown
- 2003-05-14 WO PCT/EP2003/005038 patent/WO2003100432A2/fr not_active Ceased
- 2003-05-14 EP EP03735383A patent/EP1508047B1/fr not_active Expired - Lifetime
- 2003-05-14 ES ES03735383T patent/ES2311710T3/es not_active Expired - Lifetime
- 2003-05-14 DK DK03735383T patent/DK1508047T3/da active
- 2003-05-14 AU AU2003236645A patent/AU2003236645B2/en not_active Expired
- 2003-05-14 DE DE50310283T patent/DE50310283D1/de not_active Expired - Lifetime
- 2003-05-14 IL IL16539803A patent/IL165398A0/xx unknown
- 2003-05-14 JP JP2004507838A patent/JP2005535299A/ja active Pending
- 2003-05-14 CA CA2486738A patent/CA2486738C/fr not_active Expired - Lifetime
- 2003-05-14 PT PT03735383T patent/PT1508047E/pt unknown
-
2004
- 2004-11-25 IL IL165398A patent/IL165398A/en not_active IP Right Cessation
-
2008
- 2008-09-19 CY CY20081101021T patent/CY1108358T1/el unknown
Also Published As
| Publication number | Publication date |
|---|---|
| EP1508047B1 (fr) | 2008-08-06 |
| DE10225139A1 (de) | 2004-02-26 |
| CA2486738A1 (fr) | 2003-12-04 |
| CY1108358T1 (el) | 2014-02-12 |
| ATE403874T1 (de) | 2008-08-15 |
| JP2005535299A (ja) | 2005-11-24 |
| CA2486738C (fr) | 2011-07-12 |
| SI1508047T1 (sl) | 2008-12-31 |
| EP1508047A2 (fr) | 2005-02-23 |
| AU2003236645B2 (en) | 2009-06-18 |
| IL165398A (en) | 2013-04-30 |
| WO2003100432A2 (fr) | 2003-12-04 |
| AU2003236645A1 (en) | 2003-12-12 |
| WO2003100432A3 (fr) | 2004-06-03 |
| DK1508047T3 (da) | 2008-10-20 |
| DE50310283D1 (de) | 2008-09-18 |
| PT1508047E (pt) | 2008-10-02 |
| ES2311710T3 (es) | 2009-02-16 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| IL165398A0 (en) | Method for identifying immunoreactive peptides | |
| WO2003089904A3 (fr) | Aib1 utilise en tant que marqueur pronostique et predicteur de la resistance a l'endocrinotherapie | |
| AU2002347560A1 (en) | Data processing method | |
| WO2004050707A3 (fr) | Molecules de reconnaissance specifiques de tumeurs | |
| WO2004001381A8 (fr) | Cible de surface cellulaire raag10 et famille d'anticorps reconnaissant cette cible | |
| MXPA02001228A (es) | Sistema y metodo para determinar requerimientos especificos de documentos de requerimientos generales. | |
| DK1562941T3 (da) | Trans-9,10-dehydroepothilon C og D, analoger deraf og fremstillingsmåder til fremstilling heraf | |
| AU2003221704A1 (en) | Immunogenic peptides, and method of identifying same | |
| UA84284C2 (ru) | Способы лечения, профилактики и диагностики инфекции helicobacter cerdo | |
| WO2004105574A3 (fr) | Radiotherapie guidee par images | |
| AU2001258373A1 (en) | Method for identifying helicobacter antigens | |
| WO2003073818A3 (fr) | Analyse du proteome de tumeurs pour developpement de rapport consultatif d'options therapeutiques | |
| PT1290160E (pt) | Polipeptideos pellino humanos | |
| NO972063L (no) | Isolert BMP-reseptorkinaseprotein, DNA-sekvens, rekombinant ekspresjonsvektor samt vertscelle | |
| IL207012A (en) | 28sgp medicinal product and 28sgp accent cancer treatment vaccine | |
| WO2020176461A3 (fr) | Méthodes et compositions pour le traitement du cancer neuroendocrinien de la prostate | |
| WO2002024895A3 (fr) | Facteurs de transcription et protéines à doigt de zinc | |
| WO2004020452A3 (fr) | Procede de repliement | |
| WO1998051782A3 (fr) | 3-hydroxyisobutyryl-coenzyme a hydrolase humaine | |
| AU2002365104A1 (en) | Method for the diagnosis of breast cancer diseases, associated peptides and the uses thereof | |
| WO1998057986A3 (fr) | Preprotachykinine b humaine | |
| WO2003029488A3 (fr) | Cancer | |
| WO2003091690A3 (fr) | Acides nucleiques et polypeptides associes au cancer | |
| ATE437650T1 (de) | Tyrosinasemutante und verfahren zur verwendung davon | |
| WO2003029482A3 (fr) | Diagnostic, traitement et prevention du cancer grace a la proteine cables |